• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头颈部黏膜黑色素瘤:我们现在在哪里?

Head and Neck Mucosal Melanoma: Where Are We Now?

机构信息

Department of Plastic and Reconstructive Surgery, Chang Gung Memorial Hospital, Chang Gung University and Medical College, Taiwan, Republic of China.

Department of Otolaryngology-Head and Neck Surgery, MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.

出版信息

Curr Oncol Rep. 2024 Apr;26(4):421-425. doi: 10.1007/s11912-024-01513-w. Epub 2024 Mar 21.

DOI:10.1007/s11912-024-01513-w
PMID:38512416
Abstract

PURPOSE OF REVIEW

To highlight recent and relevant treatment considerations while managing mucosal melanoma.

RECENT FINDINGS

Evidence is building to support the use of targeted therapy and immunotherapy while managing mucosal melanoma. Surgical resection with postoperative radiotherapy plays a major role in managing resectable disease. Recent studies evaluate the addition of targeted, and immunotherapies with an attempt to determine the most efficacious sequence of treatment.

摘要

目的综述

强调在治疗黏膜黑色素瘤时的最新相关治疗考虑因素。

最近的发现

有越来越多的证据支持在治疗黏膜黑色素瘤时使用靶向治疗和免疫疗法。手术切除联合术后放疗在治疗可切除疾病中起着重要作用。最近的研究评估了靶向治疗和免疫治疗的联合应用,试图确定最有效的治疗顺序。

相似文献

1
Head and Neck Mucosal Melanoma: Where Are We Now?头颈部黏膜黑色素瘤:我们现在在哪里?
Curr Oncol Rep. 2024 Apr;26(4):421-425. doi: 10.1007/s11912-024-01513-w. Epub 2024 Mar 21.
2
Comparative analysis of postoperative adjuvant therapy for head and neck mucosal melanoma in China.中国头颈部黏膜黑色素瘤术后辅助治疗的对比分析。
Acta Otolaryngol. 2021 Nov;141(11):1014-1021. doi: 10.1080/00016489.2021.1921263. Epub 2021 Nov 12.
3
An update on the current management of head and neck mucosal melanoma.头颈部黏膜黑色素瘤的当前治疗进展。
J Oral Pathol Med. 2017 Aug;46(7):475-479. doi: 10.1111/jop.12526. Epub 2017 Jan 10.
4
Definitive treatment for head and neck mucosal melanoma.头颈部黏膜黑色素瘤的确定性治疗。
Jpn J Clin Oncol. 2023 Dec 7;53(12):1112-1118. doi: 10.1093/jjco/hyad109.
5
Management of Head and Neck Mucosal Melanoma.头颈部黏膜黑色素瘤的管理
Oral Maxillofac Surg Clin North Am. 2022 May;34(2):299-314. doi: 10.1016/j.coms.2021.11.008. Epub 2022 Apr 8.
6
Review: mucosal melanoma of the head and neck.综述:头颈部黏膜黑色素瘤。
Melanoma Res. 2011 Aug;21(4):257-66. doi: 10.1097/CMR.0b013e3283470ffd.
7
Clinics, prognosis and new therapeutic options in patients with mucosal melanoma: A retrospective analysis of 75 patients.黏膜黑色素瘤患者的临床情况、预后及新治疗选择:75例患者的回顾性分析
Medicine (Baltimore). 2017 Jan;96(1):e5753. doi: 10.1097/MD.0000000000005753.
8
Oncologic outcomes, prognostic factor analysis and therapeutic algorithm evaluation of head and neck mucosal melanomas in France.法国头颈部黏膜黑色素瘤的肿瘤学结果、预后因素分析和治疗算法评估。
Eur J Cancer. 2019 Dec;123:1-10. doi: 10.1016/j.ejca.2019.09.007. Epub 2019 Oct 24.
9
Mucosal melanoma of the upper airways tract mucosal melanoma: A systematic review with meta-analyses of treatment.上呼吸道黏膜黑色素瘤:治疗的系统评价与荟萃分析
Head Neck. 2017 Apr;39(4):819-825. doi: 10.1002/hed.24652. Epub 2016 Nov 29.
10
Primary malignant mucosal melanoma of the head and neck.头颈部原发性恶性黏膜黑色素瘤
Curr Opin Otolaryngol Head Neck Surg. 2006 Apr;14(2):100-4. doi: 10.1097/01.moo.0000193176.54450.c4.

引用本文的文献

1
Treatment and related morbidity of nasal cavity and paranasal sinus cancers.鼻腔及鼻窦癌的治疗与相关发病率
Front Oncol. 2024 Sep 26;14:1422892. doi: 10.3389/fonc.2024.1422892. eCollection 2024.

本文引用的文献

1
Primary Mucosal Melanoma: Clinical Experience from a Single Italian Center.原发性黏膜黑色素瘤:来自意大利单一中心的临床经验。
Curr Oncol. 2024 Jan 22;31(1):588-597. doi: 10.3390/curroncol31010042.
2
Multicenter Evaluation of Radiation and Immune Checkpoint Inhibitor Therapy in Mucosal Melanoma and Review of Recent Literature.黏膜黑色素瘤放疗与免疫检查点抑制剂治疗的多中心评估及近期文献综述
Adv Radiat Oncol. 2023 Jul 9;9(1):101310. doi: 10.1016/j.adro.2023.101310. eCollection 2024 Jan.
3
Recurrence patterns among patients with sinonasal mucosal melanoma: A multi-institutional study.
鼻腔鼻窦黏膜黑色素瘤患者的复发模式:一项多机构研究。
Int Forum Allergy Rhinol. 2023 Dec;13(12):2156-2164. doi: 10.1002/alr.23204. Epub 2023 Jun 15.
4
Neoadjuvant Checkpoint Immunotherapy and Melanoma: The Time Is Now.新辅助检查点免疫治疗与黑色素瘤:现在正是时候。
J Clin Oncol. 2023 Jun 10;41(17):3236-3248. doi: 10.1200/JCO.22.02575. Epub 2023 Apr 27.
5
Current Trends in Mucosal Melanomas: An Overview.黏膜黑色素瘤的当前趋势:概述
Cancers (Basel). 2023 Feb 21;15(5):1356. doi: 10.3390/cancers15051356.
6
Neoadjuvant checkpoint inhibitor immunotherapy for resectable mucosal melanoma.可切除黏膜黑色素瘤的新辅助检查点抑制剂免疫疗法
Front Oncol. 2022 Oct 17;12:1001150. doi: 10.3389/fonc.2022.1001150. eCollection 2022.
7
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.新辅助西妥昔单抗治疗 II 期至 IV 期皮肤鳞状细胞癌。
N Engl J Med. 2022 Oct 27;387(17):1557-1568. doi: 10.1056/NEJMoa2209813. Epub 2022 Sep 12.
8
An Evidence-Based Staging System for Mucosal Melanoma: A Proposal.基于证据的黏膜黑色素瘤分期系统:建议。
Ann Surg Oncol. 2022 Aug;29(8):5221-5234. doi: 10.1245/s10434-022-11670-6. Epub 2022 Apr 9.
9
Relationship between Tumor Mutational Burden, PD-L1, Patient Characteristics, and Response to Immune Checkpoint Inhibitors in Head and Neck Squamous Cell Carcinoma.头颈部鳞状细胞癌中肿瘤突变负荷、程序性死亡受体配体1、患者特征与免疫检查点抑制剂反应之间的关系
Cancers (Basel). 2021 Nov 16;13(22):5733. doi: 10.3390/cancers13225733.
10
Tumor Mutational Burden as a Potential Biomarker for Immunotherapy in Pancreatic Cancer: Systematic Review and Still-Open Questions.肿瘤突变负荷作为胰腺癌免疫治疗的潜在生物标志物:系统评价与仍未解决的问题
Cancers (Basel). 2021 Jun 22;13(13):3119. doi: 10.3390/cancers13133119.